Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04CKG
|
|||
| Former ID |
DNCL003768
|
|||
| Drug Name |
Eflapegrastim
|
|||
| Synonyms |
SPI-2012
Click to Show/Hide
|
|||
| Indication | Neutropenia [ICD-11: 4B00.0; ICD-9: 288] | Approved | [1] | |
| Breast cancer [ICD-11: 2C60-2C65; ICD-10: C50] | Phase 3 | [2] | ||
| Company |
Spectrum
|
|||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 761148. | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031953) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.